← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2005First marketed drug
Jan 1, 1991First NDA
Jul 26, 2012Last known activity
Aug 14, 2020
Timeline
1970s
- May 15, 1974
medroxyprogesterone— Marketing Organization
1990s
- Jan 1, 1991
Amarin— Founded
2000s
- Jan 1, 2007
Ester Neurosciences Ltd.— Acquired
2010s
- Jul 26, 2012
icosapent ethyl— NDA Organization
- Jul 26, 2012
icosapent ethyl— NDA Secondary Org
Drugs by trial phase (1 distinct, 9 trials)
Phase 4 (1 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (2)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (9)
- NCT04460651CollaboratorPhase 3Aug 14, 2020
- NCT04505098CollaboratorPhase 4Aug 7, 2020
- NCT04412018CollaboratorPhase 2Jun 30, 2020
- NCT03428477CollaboratorPhase 3Mar 16, 2018
- NCT03885661CollaboratorPhase 1Jan 11, 2016
- NCT01492361Lead sponsorPhase 3Nov 1, 2011
- NCT01047683Lead sponsorPhase 3Dec 1, 2009
- NCT01047501Lead sponsorPhase 3Dec 1, 2009
- NCT00146211Lead sponsorPhase 3Sep 1, 2005
Details
- Founded
- Ballsbridge, IE Jan 1, 1991
- First NDA
- Jul 26, 2012
- Last known activity
- Aug 14, 2020